BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17004351)

  • 1. Wasting and lipodystrophy in patients infected with HIV: a practical approach in clinical practice.
    Fisher K
    AIDS Read; 2001 Mar; 11(3):132-3, 137-40, 147. PubMed ID: 17004351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
    Abrams D
    AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-agent/combination therapy of human immunodeficiency virus-related wasting.
    Wanke C
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):98-103. PubMed ID: 9625391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of steroids for wasting and lipodystrophy syndromes in HIV/AIDS.
    Frost KR
    AIDS Read; 2001 Mar; 11(3):130-1. PubMed ID: 17004350
    [No Abstract]   [Full Text] [Related]  

  • 5. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated wasting in the era of HAART: a practice-based approach to diagnosis and treatment.
    Steinhart CR
    AIDS Read; 2001 Nov; 11(11):557-60, 566-9. PubMed ID: 11789018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quality factor.
    HIV Hotline; 1998 May; 8(2):1-6. PubMed ID: 11365361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment.
    Polsky B; Kotler D; Steinhart C
    AIDS Patient Care STDS; 2001 Aug; 15(8):411-23. PubMed ID: 11522215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution.
    Andersen O; Pedersen SB; Svenstrup B; Hansen BR; Paulsen SK; Rathje GS; Richelsen B; Nielsen JO; Madsbad S; Iversen J; Haugaard SB
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):250-8. PubMed ID: 17524033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV wasting syndrome.
    Reiter GS
    AIDS Clin Care; 1996 Nov; 8(11):89-91, 93, 96. PubMed ID: 11363990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
    Yesalis CE
    AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counteracting muscle wasting in HIV-infected individuals.
    Dudgeon WD; Phillips KD; Carson JA; Brewer RB; Durstine JL; Hand GA
    HIV Med; 2006 Jul; 7(5):299-310. PubMed ID: 16945075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and HIV infection: contribution to disease manifestations and clinical implications.
    Falutz J
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):517-29. PubMed ID: 21663844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No attrition in research on wasting therapies.
    Gilden D
    GMHC Treat Issues; 1997; 11(4/5):9, 12-6. PubMed ID: 11364378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials update in human immunodeficiency virus wasting.
    Muurahainen N; Mulligan K
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):104-11. PubMed ID: 9625392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wasting and body changes: what do we know so far?
    Gomez E
    Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV lipodystrophy diagnosis and management. Body composition and metabolic alterations: diagnosis and management.
    Engelson ES
    AIDS Read; 2003 Apr; 13(4 Suppl):S10-4. PubMed ID: 12762288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss and disease progression in HIV infection.
    Wheeler DA
    AIDS Read; 1999 Aug; 9(5):347-53. PubMed ID: 12737124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone replacement for hypogonadism: clinical findings and best practices.
    Hengge UR
    AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life.
    Roubenoff R
    Am J Manag Care; 2000 Sep; 6(9):1003-16. PubMed ID: 11184062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.